The European Commission should shelve its patent law proposal

By |november 30th, 2018|drug approval, drug innovation, drug pricing, News, patent, SPC manufacturing waiver|

The European Commission is considering an initiative that would permanently hobble the continent's economy, writes Jan Fischer.

Komentarji so izklopljeni za The European Commission should shelve its patent law proposal

Does fast-track drugs approval in EU run too fast?

By |oktober 25th, 2018|drug approval, EFPIA, EMA, new drugs, News, PRIME, Rare Diseases Europe|

More than two years after its launch, the EU's fast-track approval process for marketing new drugs, called PRIME, is broadly welcomed by patients and industry, walking the fine line between patients' safety and expediency, and between the need to foste...

Komentarji so izklopljeni za Does fast-track drugs approval in EU run too fast?